Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03533439
Other study ID # 2013/0117
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 15, 2013
Est. completion date July 2018

Study information

Verified date January 2018
Source NHS Lothian
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Gastroschisis is one of the most common neonatal surgical conditions, and is increasing in incidence. Postnatal bowel ischemia leading to necrosis, bowel loss and short-bowel syndrome, occurs in a few instances, with significant impact. Intestinal gangrene occurs in up to 37%. The cause of the gangrene can be multifactorial. Contributing factors can be volvulus; venous engorgement with ensuing arterial compromise; constriction of the gut mesentery at the defect; and contribution of the hydrostatic effect of the column of bowel within a silo.

Theoretically, the increased hydrostatic pressure incurred by the bowel in a preformed silo, may decrease blood flow to the apex of the bowel and contribute to ischemia. However, this does not seem to be the norm, as most cases do well in the silo. Cases of intestinal ischaemia within the silo have been described in patients. Any objective measure of bowel perfusion and therefore viability which can aid clinical assessment and management may benefit patient outcome.

Near-infrared spectroscopy (NIRS) is used to noninvasively measure and monitor changes in the approximate regional haemoglobin oxygen saturation (SO2) in the blood. Measurement of oxygen saturation using NIRS is already in clinical application in other neonatal and paediatric medical and surgical diseases. NIRS has been recommended as a good trend indicator of changes in neonatal tissues oxygenation. NIRS-measured duration of cerebral oxygen desaturation is an accurate predictor of postoperative neurological injury in children undergoing cardiac surgery.

The investigators propose to use NIRS to measure SO2 in the intestinal bed in patients with gastroschisis and to ascertain if there is any clinical advantage to routine monitoring in these patients.

The aim of the study will be to:

1. Measure Gastrointestinal SO2 (GSO2) of the bowel within the silo of gastroschisis patients

2. Identify the clinical progress of patients with gastroschisis in the postnatal period

3. Identify any association of the measured GSO2 with the clinical outcome and any gastrointestinal complications


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date July 2018
Est. primary completion date August 31, 2017
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Gastroschisis diagnosed antenatally or at birth

Exclusion Criteria:

- Associated congenital condition affecting respiratory system , cardiovascular system or global development

- Generalised sepsis

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Near infrared spectroscopy
Four channel measurement of regional haemoglobin oxygen saturation (SO2) in the blood of the bowel, kidney and brain of neonates with gastroschisis during reduction within a silo and after surgery will be performed.• Routine surgical procedure will be followed (clinically indicated silo placement and closure as is currently practised). There will be no change in the clinical practice in place during this pilot study. Clinical management will be as already practiced with the supervision of the consultant with clinical responsibility dictating management

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
NHS Lothian

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of intestinal ischemia requiring intervention and its correlation to measured GSO2 Through study completion, an average of 6 weeks
Secondary Time to full feeds Through study completion, an average of 6 weeks
Secondary Changes in renal oxygenation measured by near infra-red spectroscopy Through study completion, an average of 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT00539292 - Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis Phase 2
Recruiting NCT03724214 - Multi-Centre Gastroschisis Interventional Study Across Sub-Saharan Africa N/A
Recruiting NCT01469208 - Music Therapy: An Adjunct To Gastroschisis Infants' Care N/A
Terminated NCT00404690 - Bedside Silo Versus Operative Closure for Gastroschisis N/A
Recruiting NCT05704257 - Fetal Repair of Complex Gastroschisis: A Safety and Feasibility Trial N/A
Active, not recruiting NCT03393832 - Oral Care in Infants With Gastroschisis
Completed NCT03666767 - Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries
Terminated NCT03355326 - Evaluation of Glycerin Suppositories to Improve Bowel Function in Gastroschisis Phase 4
Completed NCT03185637 - Children's Surgery in Sub-Saharan Africa N/A
Completed NCT02575846 - Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair N/A
Terminated NCT01094587 - Sutureless vs Sutured Gastroschisis Closure N/A
Active, not recruiting NCT00127946 - Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses Phase 3
Withdrawn NCT04186039 - Functional Evaluation of the Fetal Lung by Functional Magnetic Resonance Imaging - Blood Oxygenation Level Dependent (MRI-BOLD), in Congenital Diaphragmatic and Parietal Malformations N/A
Completed NCT03960320 - Health Related Quality of Life of Patients With Abdominal Wall Defects
Terminated NCT02098915 - Metoclopramide Pilot Trial Phase 3
Completed NCT01316510 - Probiotics in Infants With Gastroschisis N/A
Completed NCT04020939 - The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery. N/A
Recruiting NCT06072976 - The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies N/A
Recruiting NCT05293353 - Neokare Safety and Tolerability Assessment in Neonates With GI Problems
Completed NCT02370251 - Compassionate Use of Omegaven in Children Phase 2/Phase 3